This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Nov. 8, 2011 /PRNewswire/ - Neovasc Inc. (TSXV: NVC) today announced that chief executive officer
Alexei Marko will present at the upcoming Lazard Capital Markets 8th Annual Healthcare Conference at
4:00 PM EST on
November 15, 2011. The conference will be held at the Pierre Hotel in
New York City.
The company's presentation will be webcast live. It can be accessed at the Investors section of the Neovasc website at
www.neovasc.com or at
http://wsw.com/webcast/lz11/nvcif.pk/. An archived version of the webcast will be available for at least 30 days after the conference.
For more information about the Lazard 8th Annual Healthcare Conference, visit
About Neovasc Inc. Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. For more information, visit
SOURCE Neovasc Inc.